Anderson Hoagland & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.75M | Sell |
19,647
-176
| -0.9% | -$78.4K | 0.83% | 34 |
|
|
2025
Q1 | $9.36M | Sell |
19,823
-1,352
| -6% | -$639K | 1.11% | 26 |
|
|
2024
Q4 | $8.94M | Sell |
21,175
-87
| -0.4% | -$36.7K | 0.92% | 30 |
|
|
2024
Q3 | $9.68M | Buy |
21,262
+26
| +0.1% | +$11.8K | 0.99% | 32 |
|
|
2024
Q2 | $10.3M | Buy |
21,236
+63
| +0.3% | +$30.6K | 1.08% | 28 |
|
|
2024
Q1 | $8.42M | Buy |
21,173
+4,499
| +27% | +$1.79M | 0.94% | 33 |
|
|
2023
Q4 | $7.29M | Buy |
+16,674
| New | +$7.29M | 0.89% | 34 |
|